Clinical trial
The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in…
NCT00498667 · Rambam Health Care Campus, Other · Withdrawn
Key facts
| NCT number | NCT00498667 |
|---|---|
| Title | The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma |
| Official title | Evaluation of the Prognostic Value of Early Interim PET/CT for Prediction of Progression Free Survival of Patients With Aggressive B Cells Non Hodgkin Lymphoma |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Lymphoma, Large Cell (Diffuse) With Small Cell, Diffuse |
| Enrollment | 0 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2014 |
| First posted | Jul 10, 2007 |
| Last update posted | May 6, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: